Gubra A/S
GUBRA.CO
| Exchange: | CO |
| Currency | Danish krone |
| ISIN: | DK0062266474 |
| Primary Ticker: | GUBRA.CO |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs in Denmark and internationally. The company operates through CRO, Discovery & Partnerships, and Gubra Green segments. It offers pre-clinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, assays and molecular pharmacology, bioinformatics, bioanalysis, next gen sequencing, and 2D and 3D imaging. The company has a partnership and collaboration with Boehringer Ingelheim to discover novel peptides for the treatment of obesity. Gubra A/S was incorporated in 2008 and is based in Horsholm, Denmark. |
| Address: | Hørsholm Kongevej 11B, Horsholm, Denmark, 2970 |
| Website: | https://www.gubra.dk |
| Full Time Employees: | 235 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 6833135616 |
| Market Capitalization Mln: | 6833.13 |
| EBITDA: | -49398000 |
| Book Value: | 28.44 |
| Earnings Share: | -2.81 |
| Most Recent Quarter: | 2023-12-31 |
| Profit Margin: | -0.20 |
| Operating Margin TTM: | -0.21 |
| Return On Assets TTM: | -0.05 |
| Return On Equity TTM: | -0.09 |
| Revenue TTM: | 223815008 |
| Revenue Per Share TTM: | 13.49 |
| Quarterly Revenue Growth YOY: | 0.18 |
| Gross Profit TTM: | 97745000 |
| Diluted Eps TTM: | -2.81 |
Valuation
| Price Sales TTM: | 31.47 |
| Price Book MRQ: | 15.18 |
| Enterprise Value: | 6591841792 |
| Enterprise Value Revenue: | 29.88 |
| Enterprise Value Ebitda: | -164.33 |
Shares
| Shares Outstanding: | 16308200 |
| Shares Float: | 5759879 |
| Percent Insiders: | 69.05 |
| Percent Institutions: | 26.68 |
Technicals
| 52 Week High: | 754 |
| 52 Week Low: | 112 |
| 50 Day MA: | 480.78 |
| 200 Day MA: | 393.17 |
Earnings
| Report Date: | 2024-11-07 |
| Date: | 2024-09-30 |
| Currency: | DKK |
| Report Date: | 2024-09-26 |
| Date: | 2024-06-30 |
| Before After Market: | After Market |
| Currency: | DKK |
| Report Date: | 2024-05-07 |
| Date: | 2024-03-31 |
| Currency: | DKK |
| Report Date: | 2024-02-28 |
| Date: | 2023-12-31 |
| Currency: | DKK |
| Report Date: | 2023-11-29 |
| Date: | 2023-09-30 |
| Currency: | DKK |
| Report Date: | 2023-08-30 |
| Date: | 2023-06-30 |
| Currency: | DKK |
| Report Date: | 2023-05-31 |
| Date: | 2023-03-31 |
| Currency: | DKK |
| Date: | 2024-09-30 |
| Date: | 2023-12-31 |